← Leaderboards
Xiang Xu
Hugo W. Moser Res Inst Kennedy Krieger
$3,458,891
Attributed
$3,691,266
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,691,266 · 5
By mechanism
R21$1,394,086 · 2
R01$1,308,958 · 1
R00$746,544 · 1
K99$241,678 · 1
Top collaborators
- Benjamin H Natelson2 shared
Most similar at Hugo W. Moser Res Inst Kennedy Krieger
Same institution · by research overlap
- Qin Qin$8,863,187
- Michael T McMahon$10,109,578
- Nirbhay Narayan Yadav$2,295,035
- Wenbo Li$456,592
Others in their field
Other Emerging Leaders on “Magnetic Resonance Imaging”
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Eric C Palm · Florida State University$31,951,397
- Michael W Rabin · Florida State University$26,502,247
- Ross D McDonald · Florida State University$26,502,247
- Bryan Roth · Univ Of North Carolina Chapel Hill$21,325,531
Research focus
Magnetic Resonance ImagingImageReportingBrainGlucoseSignal TransductionProtocols DocumentationImaging TechniquesScanningDiagnosis3-DimensionalSymptomsAffectProtonsMeasurementWaterTranslationsIn VivoResolutionDepositionLesionInfusion ProceduresMonitorMotion
Grant awards (14)
Cerebral Energy Metabolism in ME/CFS with and without PASC$638,237
R01 · FY2025 · NS · contact PI
Non-invasive Magnetic Resonance Imaging of Glycogen in the Human Liver$211,250
R21 · FY2025 · AG · contact PI
Cerebral Energy Metabolism in ME/CFS with and without PASC$670,721
R01 · FY2024 · NS · contact PI
Non-invasive Magnetic Resonance Imaging of Glycogen in the Human Liver$253,500
R21 · FY2024 · AG · contact PI
In vivo measurement of Amyloid in preclinical Alzheimer's Disease by saturation transfer MRI$253,336
R21 · FY2024 · AG · contact PI
Structural and Metabolic Neuroimaging of ME/CFS Occurring with and without COVID-19 Infection$211,250
R21 · FY2023 · NS · contact PI
Non-invasive Magnetic Resonance Imaging of Glycogen in the Human Liver$211,250
R21 · FY2023 · AG · contact PI
Structural and metabolic neuroimaging of ME/CFS occurring with and without COVID-19 infection$253,500
R21 · FY2022 · NS · contact PI
Development and Translation of D-glucose as an MRI Contrast Agent for Multiple Sclerosis$248,848
R00 · FY2022 · EB · contact PI
Development and Translation of D-glucose as an MRI Contrast Agent for Multiple Sclerosis$248,848
R00 · FY2021 · EB · contact PI
Development and Translation of D-glucose as an MRI Contrast Agent for Multiple Sclerosis$248,848
R00 · FY2020 · EB · contact PI
Development and Translation of D-glucose as an MRI Contrast Agent for Multiple Sclerosis$53,758
K99 · FY2020 · EB · contact PI
Development and Translation of D-glucose as an MRI Contrast Agent for Multiple Sclerosis$93,960
K99 · FY2019 · EB · contact PI
Development and Translation of D-glucose as an MRI Contrast Agent for Multiple Sclerosis$93,960
K99 · FY2018 · EB · contact PI